Major Milestone for Evgen Pharma PLC says Northland Capital

Northland Capital partners view on Evgen Pharma PLC LON:EVG: First Patient Dosing in this trial represents another major milestone for Evgen. With two Phase 2 trials now dosing patients and with both trials fully funded, the group is well positioned to deliver significant value creation in the near future—both trials are expected to report top line results in calendar H1-2018. As such, we reiterate that the Company’s shares are significantly undervalued.

First patient dosed in breast cancer trial
n  Evgen announced that the first patient has been dosed in the Company’s Phase II clinical trial of SFX-01 in breast cancer.

n  The trial is being led by Manchester’s Christie NHS Foundation Trust, Europe’s largest single-site cancer centre, and will include approximately 15 sites in 5 countries.

n  The first patient was dosed on 16 January 2017 at the Cliniques universitaires Saint-Luc, the largest hospital in Brussels, Belgium.

n  The trial is investigating SFX-01 in combination with different hormone-based therapies in 60 metastatic breast cancer patients whose cancer cells are estrogen-receptor positive (ER+).

n  Evgen also announced the appointment of a new CFO and Head of Clinical Operations.

Year end Mar Revs (£m) Adj. EBITDA (£m) Adj. PBT (£m) Tax (%) Adj. EPS (p) PER (x) Div (p) Net cash (£m) Yield (%)
2015A (1) (2) (0) (1)
2016A (2) (3) (0) 7
2017E (4) (4) (0) 4
2018E 5 1 1 0 6

Source: Northland Capital Partners Limited. *Northland Capital Partners acts as Nomad and Broker

 

 

 

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    X
    LinkedIn
    Evgen Pharma Plc

    More articles like this

    Evgen Pharma Plc

    21 Health Benefits of Broccoli

    Are you looking for a vegetable to spice up your diet in a healthy way? If yes, then broccoli, also called Brassica oleracea italica, is the vegetable you want. The dark green crucifer is not only

    Evgen Pharma Plc

    12 things that are actually tied to breast cancer

    According to the Centres for Disease Control and Prevention (CDC), breast cancer is the most common cancer in women. In the US, one in eight women will develop breast cancer during her lifetime. Those statistics sound

    Evgen Pharma Plc

    10 subtle signs of breast cancer

    A diagnosis of breast cancer can be terrifying. According to the CDC, Breast cancer is the most common cancer in American women of any race or ethnicity. Though the statistics might be scary, catching breast cancer

    Evgen Pharma Plc

    Evgen Pharma plc Investor Presentation in Manchester

    Evgen Pharma plc (LON: EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, announces that Steve Franklin, the Company’s CEO, will be presenting tomorrow evening at a ShareSoc Growth

    Evgen Pharma Plc

    ‘I never knew men could get breast cancer’

    Moses Musonga never thought men could get breast cancer until he was diagnosed with the disease in 2013. The 67-year-old Kenyan told the BBC that he was profoundly shock when doctors told him in 2013 that

    Evgen Pharma Plc

    Male Breast cancer:What are the signs and how to check?

    Breast cancer is more commonly associated with women more than with men, affecting approximately one in eight women in their lifetimes. However, men can still be diagnosed with breast cancer, albeit in far rarer circumstances. While